Pathophysiologic Basis and Clinical Rationale for Early Ambulatory Treatment of COVID-19
3 years ago
It is our honor to bring Dr. McCullough back to "Doctors Are In" to discuss the latest on reducing COVID-19 hospitalization and death with early treatment with an in depth overview and update on ambulatory treatment studies and the new sequenced, multi-drug therapeutic regimen for high-risk COVID-19 patients. https://rcm.imrpress.com/article/2020/2153-8174/RCM2020264.shtml
Loading comments...
-
7:06
Association of American Physicians and Surgeons
1 month agoDr. McCullough on RFK Selection for HHS Secretary
1.43K -
4:46
WMAR
4 years agoCOVID-19 Early Treatment Fund
1.15K -
2:33
KGTV
3 years agoSupercomputer simulates COVID-19 treatment
1551 -
0:20
WFTX
3 years agoNew COVID-19 vaccine clinical trial
238 -
2:11
WCPO
3 years agoStudy: Concerns surrounding COVID-19 treatment Remdesivir
6063 -
0:43
KMGH
4 years agoUCHealth testing Bimlanivimab - Covid-19 antibody treatment
85 -
2:05
KGTV
4 years agoPresident Trump's COVID-19 antibody treatment
1.58K1 -
2:38
KJRH
3 years agoMonoclonal antibodies treatment used in high-risk COVID-19 patients
522 -
0:32
KTNV
3 years agoCOVID-19 antibody treatment being used in Las Vegas
164 -
0:24
Newsy
4 years agoFDA Approves Emergency COVID-19 Antibody Treatment
1.15K